Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Annals of Hematology|February 9, 2012
A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myelomaJae-Sook Ahn, Deok-Hwan Yang, Sung-Hoon Jung, et al.
The Korean Journal of Hematology|November 9, 2011
Fludarabine-containing chemotherapy for patients with previously untreated low-grade non-Hodgkin's lymphomaJae-Sook Ahn, Deok-Hwan Yang, Sung-Hoon Jung, et al.
Blood Research|July 22, 2025
Current practices in peripheral blood stem cell processing and cryopreservation: a nationwide survey of Korean transplant centersSoo-Kyung Kim, Jaeeun Yoo, Jong-Han Lee, et al.
Journal of Korean Medical Science|February 13, 2013
Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin AHuong Thi Thanh Tran, Hee Nam Kim, Il-Kwon Lee, et al.
Journal of Korean Medical Science|January 4, 2022
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell LymphomaMihee Kim, Seo-Yeon Ahn, Jae-Sook Ahn, et al.
Translational Oncology|April 12, 2022
Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myelomaTan-Huy Chu, Manh-Cuong Vo, Thangaraj Jaya Lakshmi, et al.
Tuberculosis and Respiratory Diseases|June 11, 2013
Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with LymphomaHyung Chul Park, Jae-Sook Ahn, Deok-Hwan Yang, et al.
Blood Research|February 24, 2022
Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimenSu-In Kim, Sung-Hoon Jung, Ho-Young Yhim, et al.
Blood|October 14, 2016
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapyTaeHyung Kim, Marc S Tyndel, Hyeoung Joon Kim, et al.
Therapeutic Advances in Hematology|November 6, 2023
Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitorHyunkyung Park, Hyeong-Joon Kim, Sang-Kyun Sohn, et al.
Pageof 16